In vivo assessment of the antimicrobial activity of a calcium-deficient apatite vancomycin drug delivery system in a methicillin-resistant staphylococcus aureus rabbit osteomyelitis experimental model

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 2, 2010, Pages 950-952

  Amador, G ^a,b   Gautier, H ^c   Le Mabecque, V ^b   Miegeville, A F ^b   Potel, G ^a,b   Bouler, J M ^c   Weiss, P ^c   Caillon, J ^a,b   Jacqueline, C ^b  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c Universite de Nantes   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APATITE; BIOMATERIAL; CALCIUM; CALCIUM DEFICIENT APATITE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANIMAL EXPERIMENT; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; BONE; BONE MARROW; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DOSE COMPARISON; DRUG INFUSION; IN VIVO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; OSTEOMYELITIS; PRIORITY JOURNAL; RABBIT; SYNOVIAL FLUID; TISSUE;

ANIMALS; ANTI-BACTERIAL AGENTS; APATITES; BONE AND BONES; BONE MARROW; CALCIUM; DRUG DELIVERY SYSTEMS; FEMALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; OSTEOMYELITIS; RABBITS; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN;

EID: 75749124214     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00434-09     Document Type: Article

References (12)

1. Berbari, E. F., J. M. Steckelberg, and D. R. Osmon. 2005. Osteomyelitis, p. 99. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases, 6th ed. Churchill Livingstone, London, United Kingdom.
2. Bourgeois, B., O. Laboux, L. Obadia, O. Gauthier, E. Betti, E. Aguado, G. Daculsi, and J. M. Bouler. 2003. Calcium-deficient apatite: a first in vivo study concerning bone ingrowth. J. Biomed. Mater. Res. A 65(3):402-408.
3. Darley, E. S. R., and A. P. MacGowan. 2004. Antibiotic treatment of Grampositive bone and joint infections. J. Antimicrob. Chemother. 53:928-935.
4. Duckworth, G. J. 1993. Diagnosis and management of methicillin resistant Staphylococcus aureus infection. BMJ 307:1049-1052.
5. Espinoza, L. R. 2007. Infections of bursae, joints, and bones, p. 293. In L. Goldman and D. Ausiello (ed.), Cecil medicine, 23rd ed. Saunders Elsevier, Philadelphia, PA.
6. Hawkshead, J. J., III, N. B. Patel, R. W. Steele, and S. D. Heinrich. 2009. Comparative severity of pediatric osteomyelitis attribuable to methicillinresistant versus methicillin-sensitive Staphylococcus aureus. J. Pediatr. Orthop. 29(1):85-90.
7. Henry, S. L., and K. P. Galloway. 1995. Local antibacterial therapy for the management of orthopaedic infections. Pharmacokinetic considerations. Clin. Pharmacokinet. 29(1):36-45.
8. Obadia, L., G. Amador, G. Daculsi, and J. M. Bouler. 2003. Calcium-deficient apatite: influence of granule size and consolidation mode on release and in vitro activity of vancomycin. Biomaterials 24:1265-1270.
9. Sax, H., and D. Lew. 1999. Osteomyelitis. Curr. Infect. Dis. Rep. 1:261-266.
10. Waldvogel, F. A., and H. Vasey. 1980. Osteomyelitis: the past decade. N. Engl. J. Med. 303:360-370.
11. Wysocki, M., F. Delatour, F. Faurisson, A. Rauss, Y. Pean, B. Misset, F. Thomas, J. F. Timsit, T. Similowski, H. Mentec, L. Mier, D. Dreyfus, and the study group. 2001. Continuous versus intermittent infusion of vancomycin in severe staphylococcal infections: prospective multicenter randomized study. Antimicrob. Agents Chemother. 45:2460-2467.
12. Yin, L. Y., L. Lazzarini, F. Li, C. M. Stevens, and J. H. Calhoun. 2005. Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model. J. Antimicrob. Chemother. 55:995-1002.